-- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...

Most DNA extraction protocols were originally developed for manual pipetting and later adapted for liquid handlers. In ...

The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing ...

Oncology leaders appearing in Atlanta, Georgia, including several from Winship Cancer Institute from Emory University School of Medicine, show how NGS biomarkers and MRD reshape NSCLC and hematology ...

OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.

After years of operating in the research markets, IDT has launched IVD assays based on the core chemistry capabilities from the company's Archer portfolio.

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

Illumina and Labcorp expand collaboration to advance precision oncology through innovative applications of NGS solutions: San Diego Friday, March 20, 2026, 15:00 Hrs [IST] Illumin ...

The state has a cutting-edge system built during COVID but that can detect other viruses and diseases.

Josh Lauer explores the trends shaping sequencing, the science behind SBX technology, and how AXELIOS 1 is designed to ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...